Using NMR spectroscopy in the fragment-based drug discovery of small-molecule anti-cancer targeted therapies.
2020
Against the challenge of providing personalized cancer care, the development of targeted therapies stands as a promising approach. The discovery of these agents can benefit from fragment-based drug discovery (FBDD) methods that help guide ligand design and provide key structural information on the targets of interest. In particular, nuclear magnetic resonance (NMR) spectroscopy is a promising biophysical tool in fragment discovery due to its detection capabilities and versatility. This review article provides an overview of FBDD, describes the basis of NMR-based fragment screening, summarizes some exciting technical advances reported over the past decades, and closes with a discussion of selected case studies where this technique has been used as part of drug discovery campaigns to produce lead compounds towards the design of anti-cancer targeted therapies.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
185
References
4
Citations
NaN
KQI